Centene Corporation

NYSE:CNC Rapport sur les actions

Capitalisation boursière : US$31.4b

Centene Croissance future

Future contrôle des critères 1/6

Centene devrait augmenter ses bénéfices et son chiffre d'affaires de 4.9% et de 5.7% par an respectivement. Le BPA devrait croître de de 9.7% par an. Le rendement des capitaux propres devrait être 12.9% dans 3 ans.

Informations clés

4.9%

Taux de croissance des bénéfices

9.7%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.7%
Taux de croissance des recettes5.7%
Rendement futur des capitaux propres12.9%
Couverture par les analystes

Good

Dernière mise à jour31 Oct 2024

Mises à jour récentes de la croissance future

Recent updates

Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024

Oct 22

Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch

Oct 14
Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch

Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Sep 26
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger

Sep 08
Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Aug 20
Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy

Aug 20

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Aug 02
Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

Jun 22
Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Jun 04
A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

May 14
Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Apr 26
These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Centene Corporation Still An Opportunity With An A-Grade Valuation

Mar 31

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Mar 15
If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Feb 08
Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Jan 22

Is Centene (NYSE:CNC) Using Too Much Debt?

Jan 21
Is Centene (NYSE:CNC) Using Too Much Debt?

Centene: Overlooked Healthcare Giant

Nov 21

Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Nov 10
Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Oct 26

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Decoding Centene: Why I Think It's Undervalued

Oct 10

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Jul 31
If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Centene: Results Impress But Buyers Aren't Swarming Yet

Jul 27

Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Jul 12
Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Apr 10
Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M

Feb 07

With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Jan 27
With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Dec 27
Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Centene: Once Again, With Quality, Now A 'Buy'

Dec 23

Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid

Dec 14

An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued

Nov 11
An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued

Prévisions de croissance des bénéfices et des revenus

NYSE:CNC - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026171,3883,4304,0705,29913
12/31/2025164,1093,0163,8274,95315
12/31/2024161,1913,1101,8882,5249
9/30/2024146,2043,067245958N/A
6/30/2024144,0642,8232,2612,957N/A
3/31/2024142,8002,7352,6033,328N/A
12/31/2023141,2662,7027,2548,053N/A
9/30/2023139,3642,4445,4516,260N/A
6/30/2023138,1112,7137,6518,571N/A
3/31/2023136,9411,4838,3929,379N/A
12/31/2022135,9991,2025,2576,261N/A
9/30/2022132,7562,0147,4938,512N/A
6/30/2022129,2281,8605,9856,982N/A
3/31/2022124,1811,4974,3485,313N/A
12/31/2021118,5731,3473,2954,205N/A
9/30/2021114,1307365,6436,511N/A
6/30/2021111,2847202,8633,757N/A
3/31/2021108,1582,4614,9075,786N/A
12/31/2020104,2801,8084,6345,503N/A
9/30/202095,7642,0291,0081,871N/A
6/30/202086,5231,5561,9182,724N/A
3/31/202078,105845-804-73N/A
12/31/201970,8071,3217531,483N/A
9/30/201968,3851,3537841,500N/A
6/30/201965,5071,2771,4982,147N/A
3/31/201961,0281,08271704N/A
12/31/201856,6889005591,234N/A
9/30/201852,6188891,7082,318N/A
6/30/201848,6551,075N/A1,867N/A
3/31/201847,2011,029N/A2,087N/A
12/31/201745,810828N/A1,489N/A
9/30/201744,870853N/A2,631N/A
6/30/201743,646796N/A3,016N/A
3/31/201742,468713N/A2,903N/A
12/31/201637,693562N/A1,851N/A
9/30/201632,839416N/A460N/A
6/30/201628,062360N/A40N/A
3/31/201622,948277N/A809N/A
12/31/201521,292356N/A658N/A
9/30/201519,854350N/A827N/A
6/30/201518,548339N/A1,206N/A
3/31/201517,102298N/A1,016N/A
12/31/201415,689268N/A1,223N/A
9/30/201414,134210N/A1,023N/A
6/30/201412,700179N/A713N/A
3/31/201411,475172N/A591N/A
12/31/201310,544161N/A382N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CNC ( 4.9% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de CNC ( 4.9% par an) devraient croître plus lentement que le marché US ( 15.2% par an).

Croissance élevée des bénéfices: Les bénéfices de CNC devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CNC ( 5.7% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CNC ( 5.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de CNC devrait être faible dans 3 ans ( 12.9 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y